Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
1998-02-28
2004-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Thirty ceramic FPD core frameworks were prepared using a hot-pressing technique and a lithia-disilicate-based core ceramic. The maximum clenching force was measured for each patient prior to tooth preparation. Connector heights and widths were measured for each FPD. Patients were recalled yearly after cementation for two years and evaluated using eleven clinical criteria. All FPDs were examined by two independent clinicians and rankings for each criterion were made from 1 to 4 with 4 = excellent and 1 = unacceptable.
The aims of this research were:
1. To test the hypotheses that three-unit fixed partial dentures (FPDs) of a high-strength core ceramic will exhibit good-to-excellent clinical performance (based on 11 evaluative criteria) and that they will adequately resist fracture in posterior situations (excluding third molars) if fabricated with the minimal connector size (4 mm x 4 mm).
2. To test the hypothesis that a reinforced glass ionomer cement (ProTec CEM, Ivoclar, Vivadent), when used to cement core ceramic crowns in posterior FPDs, will be associated with significantly less marginal quality, but similar fracture resistance of the ceramic crowns compared with the marginal quality associated with a dual cure resin cement (Variolink® II, Ivoclar Vivadent AG, Schaan, Liechtenstein).
3. To test the hypothesis that there is no significant difference in tooth sensitivity associated with FPDs cemented with the glass ionomer cement and dual-cure resin cement.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. General medical history and physical examination
2. Primary casts made with irreversible hydrocolloid impression material
3. Bite force measurement in Newtons made with a gnathodynamometer
4. Pocket depths of abutment teeth
5. Periapical radiographs of abutment teeth. The maximum occlusal force exerted by each subject was measured prior to commencing treatment using a bite force gauge that has been reported previously by Gibbs et al.12 The purpose of these measurements was to analyze the influence of occlusal force on the survival of the FPDs. A total of 30 FPDs were fabricated for 21 patients with the core ceramic and all patients were recalled each year for two years. Three clinicians performed treatment and one technician using an in-house laboratory accomplished all labwork. Out of the 21 patients, 18 were female and 3 were male with ages ranging from 30 to 62 years of age. The 3-unit FPDs were located in the posterior area with canines serving as the most anterior abutment and second molars as the most posterior abutment. All FPDs were opposed by natural dentition. The dimensions for tooth reduction included at least 1 mm of axial reduction; 2 mm of occlusal reduction and incorporation of a shoulder or a deep chamfer margin design with rounded line angles. Final impressions were made using a dual impression technique with high and low viscosity polyvinylsiloxane in a stock tray. Provisional resin FPDs were made and cemented with temporary cement. FPDs were processed by hot-pressing the core ceramic (Ivoclar Vivadent AG, Schaan, Liechtenstein) and applying stain and glaze as necessary. The heat-pressed ceramic system uses the lost wax technique whereby the FPD is waxed to its proper shape and contour and then invested in a special flask with a special type of investment material. The desired shade of a precerammed ceramic cylinder is plasticized at 1100oC and pressed under vacuum and pressure into the mold of the investment.13 The ceramic FPDs were inspected to ensure that the incisogingival height and curvature of the gingival embrasure of the connectors were adequate to resist fracture when subjected to normal biting forces. The minimal dimensions recommended for premolar FPDs, 4 mm x 4 mm, and for molar FPDs, 4 mm x 5 mm, were applied for each FPD when esthetics and gingival contour permitted. Connector heights and widths were measured for each FPD using a boley gauge. FPDs were cemented using either a resin-reinforced glass ionomer cement (Protec CEM, Vivadent) or a dual-cure resin cement (Variolink II, Vivadent) using a random number table. Fourteen (14) FPDs were cemented with the resin-reinforced glass ionomer and 13 with the dual cure resin. Patients were recalled after cementation annually for two years and evaluated for the following clinical criteria: (1) tissue health; (2) secondary caries; (3) occlusion; (4) proximal contact; (5) marginal integrity; (6) absence of sensitivity to percussion, heat, cold, and air; (7) color match; (8) surface texture; (9) absence of wear of opposing teeth; (10) anatomic contour; and (11) no cracks/chips or fracture. This evaluative system was derived from the California Dental Association quality assessment evaluation system.14 FPDs were examined by two independent clinicians who did not prepare the teeth or cement the prosthesis, and rankings of each criterion were made from 1 to 4 with 4 = excellent, 3 = good, 2 = unacceptable (needs repair or replacement in the near future), and 1 = unacceptable (needs immediate replacement). All clinicians/evaluators were subjected to several calibration exercises that consisted of table top analysis of marginal openings as well as slide evaluations of different clinical situations.
Data were analyzed by logistic regression analysis of the variables with α = 0.05. The consistency of the examiners' scores was evaluated for consistency using a test for the standard deviation of inter-examination.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
all-ceramic fixed partial denture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* periodontal pockets of less than 4 mm for each abutment with no periodontal disease
* vital abutment teeth
* crown root ratio of at least 1:1.
Exclusion Criteria
* parafunctional habits
* inability to ensure residence in the area for the next five years
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ivoclar Vivadent AG
INDUSTRY
The University of Texas Health Science Center at San Antonio
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth J Anusavice, PhD, DMD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Florida College of Dentistry
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Esquivel-Upshaw JF, Anusavice KJ, Young H, Jones J, Gibbs C. Clinical performance of a lithia disilicate-based core ceramic for three-unit posterior FPDs. Int J Prosthodont. 2004 Jul-Aug;17(4):469-75.
Gibbs CH, Anusavice KJ, Young HM, Jones JS, Esquivel-Upshaw JF. Maximum clenching force of patients with moderate loss of posterior tooth support: a pilot study. J Prosthet Dent. 2002 Nov;88(5):498-502. doi: 10.1067/mpr.2002.129062.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
114-1998
Identifier Type: -
Identifier Source: org_study_id